Cover Image
市場調查報告書

嬰兒血管瘤:全球臨床實驗檢討

Infantile Hemangiomas Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 296479
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
嬰兒血管瘤:全球臨床實驗檢討 Infantile Hemangiomas Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月19日 內容資訊: 英文 67 Pages
簡介

本報告提供嬰兒血管瘤的臨床研究最新趨勢相關分析,以疾病概要為首,提供G7各國·E7各國的臨床實驗狀況,各地區、各階段的進行狀況,受驗者的募集情況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

目錄

簡介

  • 嬰兒血管瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家臨床實驗數量
    • 臨床實驗數量歐洲的主要5個國家
    • 北美的主要國家臨床實驗數量
    • 中東·非洲的主要國家臨床實驗數量
    • 中南美的主要國家臨床實驗數量

在G7各國臨床實驗數量:佔皮膚病整體比率

在G7各國臨床實驗數量:各階段

在G7各國臨床實驗數量:各進展狀況

在E7各國臨床實驗數量:佔皮膚病整體比率

在E7各國臨床實驗數量:各階段

各階段臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

在各階段的實驗完成情形

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商種類別臨床實驗量

有潛力的贊助商

  • 參加嬰兒血管瘤治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Laboratoires Pierre Fabre SA
    • InfectoPharm Arzneimittel und Consilium GmbH
  • 有代表性的研究機關·政府機關臨床實驗概要
    • Instituto Cientifico y Tecnologico de Navarra
    • The Children's Hospital of Philadelphia
    • 東京大學
    • Medical College of Wisconsin
    • Seattle Children's Hospital, Research and Foundation
    • University of Sao Paulo
    • The University of Texas Health Science Center at San Antonio
    • University Hospital, Bordeaux
    • The Hospital for Sick Children
    • Oregon Health and Science University

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC1973CTIDB

GlobalData's clinical trial report, "Infantile Hemangiomas Global Clinical Trials Review, H1, 2014" provides data on the Infantile Hemangiomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infantile Hemangiomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Infantile Hemangiomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Infantile Hemangiomas
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Infantile Hemangiomas to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Infantile Hemangiomas to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Infantile Hemangiomas
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Infantile Hemangiomas Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Laboratoires Pierre Fabre SA
      • Clinical Trial Overview of Laboratoires Pierre Fabre SA
      • InfectoPharm Arzneimittel und Consilium GmbH
      • Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH
    • Clinical Trial Overview of Top Institutes / Government
      • Instituto Cientifico y Tecnologico de Navarra
      • Clinical Trial Overview of Instituto Cientifico y Tecnologico de Navarra
      • The Children's Hospital of Philadelphia
      • Clinical Trial Overview of The Children's Hospital of Philadelphia
      • The University of Tokyo
      • Clinical Trial Overview of The University of Tokyo
      • Medical College of Wisconsin
      • Clinical Trial Overview of Medical College of Wisconsin
      • Seattle Children's Hospital, Research and Foundation
      • Clinical Trial Overview of Seattle Children's Hospital, Research and Foundation
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • The University of Texas Health Science Center at San Antonio
      • Clinical Trial Overview of The University of Texas Health Science Center at San Antonio
      • University Hospital, Bordeaux
      • Clinical Trial Overview of University Hospital, Bordeaux
      • The Hospital for Sick Children
      • Clinical Trial Overview of The Hospital for Sick Children
      • Oregon Health and Science University
      • Clinical Trial Overview of Oregon Health and Science University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Region, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, E7 Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Infantile Hemangiomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by InfectoPharm Arzneimittel und Consilium GmbH, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Cientifico y Tecnologico de Navarra, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, Research and Foundation, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014*

List of Figures

  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, E7 Countries (%), 2014*
  • Infantile Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Infantile Hemangiomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Infantile Hemangiomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top